USPTO trademark

TYVASO SMI

Under examinationUSPTOWord markClass 5Class 10

"TYVASO SMI" is a word mark owned by United Therapeutics Corporation, filed at the USPTO on October 23, 2026. It is under examination and covers classes 5 and 10.

Official USPTO record
TYVASO SMI trademark as filed
As filed with the USPTO
Status
Under examination
Since October 23, 2026
Filed
October 23, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50178526
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
2 classes
Ownership

Who owns TYVASO SMI

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services TYVASO SMI is filed for, grouped by Nice class.

  • Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers for medical purposes, sold filled with pharmaceutical preparations for treating pulmonary fibrosis and other pulmonary conditions

  • Chambers for inhalers; Inhalers for medical purposes, sold empty; Medical apparatus for facilitating the inhalation of pharmaceutical preparations

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application entered
FAQ

About TYVASO SMI

Who owns the trademark "TYVASO SMI"?

The USPTO trademark "TYVASO SMI" (application 50178526) is owned by United Therapeutics Corporation.

What is the status of "TYVASO SMI"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull TYVASO SMI and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_01a16e04-03bd-7355-9163-6a780bf99f98
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a16e04-03bd-7355-9163-6a780bf99f98",
  "object": "trademark",
  "mark_text": "TYVASO SMI",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50178526",
  "filing_date": "2026-10-23",
  "nice_classes": [
    5,
    10
  ],
  "owners": [
    {
      "name": "United Therapeutics Corporation",
      "entity_id": "ent_01a02a6b-39a8-7144-9f55-d3b2c419290f"
    }
  ]
}